These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 7654141

  • 1. In vitro metabolism of cyclosporin A with rabbit renal or hepatic microsomes: analysis by HPLC-FPIA and HPLC-MS.
    Pham-Huy C, Sadeg N, Becue T, Martin C, Mahuzier G, Warnet JM, Hamon M, Claude JR.
    Arch Toxicol; 1995; 69(5):346-9. PubMed ID: 7654141
    [Abstract] [Full Text] [Related]

  • 2. The dose-dependent inhibition of rat renal translation elongation seen after in vivo cyclosporin A is not caused by cyclosporin metabolites.
    Buss WC, Bowers LD.
    Toxicology; 1995 Jun 26; 100(1-3):17-25. PubMed ID: 7624874
    [Abstract] [Full Text] [Related]

  • 3. Semipreparative chromatographic separation of cyclosporin G metabolites generated by microsomes from rabbits treated with rifampicin.
    Liu WT, Tamolang MB, Pang H, Ren Y, Wong PY.
    J Pharmacol Toxicol Methods; 1996 Jun 26; 35(3):121-9. PubMed ID: 8782089
    [Abstract] [Full Text] [Related]

  • 4. Characterization of rat cytochrome P450 isozymes involved in the covalent binding of cyclosporin A to microsomal proteins.
    Sadrieh N, Thomas PE.
    Toxicol Appl Pharmacol; 1994 Aug 26; 127(2):222-32. PubMed ID: 8048065
    [Abstract] [Full Text] [Related]

  • 5. A rifampicin-induced hepatic microsomal enzyme system for the generation of cyclosporine metabolites.
    Tamolang MB, Liu WT, Pang H, Ren Y, Wong PY.
    Pharmacol Res; 1995 Sep 26; 32(3):141-8. PubMed ID: 8745344
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Metabolism of the immunosuppressant tacrolimus in the small intestine: cytochrome P450, drug interactions, and interindividual variability.
    Lampen A, Christians U, Guengerich FP, Watkins PB, Kolars JC, Bader A, Gonschior AK, Dralle H, Hackbarth I, Sewing KF.
    Drug Metab Dispos; 1995 Dec 26; 23(12):1315-24. PubMed ID: 8689938
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The effect of the new immunosuppressive drug FK506 on the formation of secondary metabolites of cyclosporin A.
    Bauer S, Brockmöller J, Kewitz H, Roots I.
    Int J Clin Pharmacol Ther Toxicol; 1992 Nov 26; 30(11):540-2. PubMed ID: 1283385
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Cyclosporin A metabolism in human liver, kidney, and intestine slices. Comparison to rat and dog slices and human cell lines.
    Vickers AE, Fischer V, Connors S, Fisher RL, Baldeck JP, Maurer G, Brendel K.
    Drug Metab Dispos; 1992 Nov 26; 20(6):802-9. PubMed ID: 1362930
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. In vitro metabolism of alisol A and its metabolites' identification using high-performance liquid chromatography-mass spectrometry.
    Yu Y, Liu Z, Ju P, Zhang Y, Zhang L, Bi K, Chen X.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Dec 15; 941():31-7. PubMed ID: 24184833
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.